Varenicline for smoking cessation among methadone-maintained smokers: A randomized clinical trial ☆
Michael D. Stein,Michael D. Stein,Celeste M. Caviness,Megan E. Kurth,Daniel Audet,J. Olson,Bradley J. Anderson +6 more
Reads0
Chats0
TLDR
Varenicline did not increase quit rates over placebo in methadone-maintained smokers and nicotine replacement therapy that combines nicotine patch prescription plus ad libitum nicotine rescue, for smoking cessation was used.About:
This article is published in Drug and Alcohol Dependence.The article was published on 2013-12-01 and is currently open access. It has received 59 citations till now. The article focuses on the topics: Smoking cessation & Nicotine replacement.read more
Citations
More filters
Journal ArticleDOI
Nicotine receptor partial agonists for smoking cessation
TL;DR: The main outcome measured was abstinence from smoking at longest follow-up, and the most rigorous definition of abstinence was abstinence, and preferred biochemically validated rates where they were reported.
Journal ArticleDOI
Nicotine replacement therapy versus control for smoking cessation
TL;DR: The effectiveness and safety of nicotine replacement therapy, including gum, transdermal patch, intranasal spray and inhaled and oral preparations, for achieving long-term smoking cessation, compared to placebo or 'no NRT' interventions was determined.
Journal ArticleDOI
Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis.
TL;DR: This meta-analysis found no evidence of an increased risk of suicide or attempted suicide, suicidal ideation, depression, or death with varenicline and provided some reassurance for users and prescribers regarding the neuropsychiatric safety of varenICline.
Journal ArticleDOI
A systematic review of smoking cessation interventions for adults in substance abuse treatment or recovery
TL;DR: NRT, behavioral support, and combination approaches appear to increase smoking abstinence in those treated for substance use disorders.
Journal ArticleDOI
Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders.
TL;DR: Tobacco cessation interventions were significantly associated with tobacco abstinence for two types of interventions, and offering tobacco cessation therapy to people in treatment or recovery for other drug dependence was not associated with a difference in abstinence rates from alcohol and other drugs.
References
More filters
Journal ArticleDOI
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.
TL;DR: A revision of the FTQ: the Fagerström Test for Nicotine Dependence (FTND), which found that a revised scoring of time to the first cigarette of the day (TTF) and number of cigarettes smoked per day (CPD) improved the scale.
Book ChapterDOI
Timeline Follow-Back A Technique for Assessing Self-Reported Alcohol Consumption
Linda C. Sobell,Mark B. Sobell +1 more
TL;DR: Concerns about how best to measure drinking patterns and problems date back to at least 1926, when Pearl stressed the importance of separating steady daily drinkers from occasional heavy drinkers.
Treating Tobacco Use and Dependence: 2008 Update
TL;DR: The Panel recognized that variations in study inclusion criteria sometimes were warranted and made recommendations based on evidence, which occurred with topics such as tobacco dependence treatment in specific populations, tailoring interventions, and cost-effectiveness of Tobacco dependence treatment.
Journal ArticleDOI
Nicotine replacement therapy for smoking cessation.
Lindsay F Stead,Rafael Perera,Chris Bullen,David Mant,Jamie Hartmann-Boyce,Kate Cahill,Tim Lancaster +6 more
TL;DR: In this article, the effectiveness of different forms of nicotine replacement therapy (chewing gum, transdermal patches, nasal spray, inhalers and tablets) in achieving abstinence from cigarettes, or a sustained reduction in amount smoked; to determine whether the effect is influenced by the clinical setting in which the smoker is recruited and treated, the dosage and form of the NRT used, or the intensity of additional advice and support offered to the smoker.